232 related articles for article (PubMed ID: 23526410)
1. Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide.
Shonka NA; Theeler B; Cahill D; Yung A; Smith L; Lei X; Gilbert MR
J Neurooncol; 2013 Jun; 113(2):305-11. PubMed ID: 23526410
[TBL] [Abstract][Full Text] [Related]
2. Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma.
Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
J Neurooncol; 2012 Nov; 110(2):227-35. PubMed ID: 22875708
[TBL] [Abstract][Full Text] [Related]
3. The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.
Kizilbash SH; Giannini C; Voss JS; Decker PA; Jenkins RB; Hardie J; Laack NN; Parney IF; Uhm JH; Buckner JC
J Neurooncol; 2014 Oct; 120(1):85-93. PubMed ID: 24993250
[TBL] [Abstract][Full Text] [Related]
4. Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
Chang S; Zhang P; Cairncross JG; Gilbert MR; Bahary JP; Dolinskas CA; Chakravarti A; Aldape KD; Bell EH; Schiff D; Jaeckle K; Brown PD; Barger GR; Werner-Wasik M; Shih H; Brachman D; Penas-Prado M; Robins HI; Belanger K; Schultz C; Hunter G; Mehta M
Neuro Oncol; 2017 Feb; 19(2):252-258. PubMed ID: 27994066
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
[TBL] [Abstract][Full Text] [Related]
6. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R;
Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.
Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS
J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233
[TBL] [Abstract][Full Text] [Related]
8. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
[TBL] [Abstract][Full Text] [Related]
9. Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide.
McTyre E; Lucas JT; Helis C; Farris M; Soike M; Mott R; Laxton AW; Tatter SB; Lesser GJ; Strowd RE; Lo HW; Debinski W; Chan MD
Am J Clin Oncol; 2018 Aug; 41(8):813-819. PubMed ID: 28301347
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).
Scoccianti S; Magrini SM; Ricardi U; Detti B; Krengli M; Parisi S; Bertoni F; Sotti G; Cipressi S; Tombolini V; Dall'oglio S; Lioce M; Saieva C; Buglione M; Mantovani C; Rubino G; Muto P; Fusco V; Fariselli L; de Renzis C; Masini L; Santoni R; Pirtoli L; Biti G
Neuro Oncol; 2012 Jun; 14(6):798-807. PubMed ID: 22539339
[TBL] [Abstract][Full Text] [Related]
11. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D
J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562
[TBL] [Abstract][Full Text] [Related]
12. High-grade glioma in children and adolescents: a single-center experience.
Yazici G; Zorlu F; Cengiz M; Ozyigit G; Eren G; Yüce D; Varan A; Akyuz C; Akalan N; Gurkaynak M
Childs Nerv Syst; 2016 Feb; 32(2):291-7. PubMed ID: 26679932
[TBL] [Abstract][Full Text] [Related]
13. The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide.
Strowd RE; Abuali I; Ye X; Lu Y; Grossman SA
J Neurooncol; 2016 Mar; 127(1):165-71. PubMed ID: 26729269
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant temozolomide-based chemoradiotherapy versus radiotherapy alone in patients with WHO III astrocytoma: The Mainz experience.
Mayer A; Schwanbeck C; Sommer C; Stockinger M; Giese A; Renovanz M; Vaupel P; Schmidberger H
Strahlenther Onkol; 2015 Aug; 191(8):665-71. PubMed ID: 26025143
[TBL] [Abstract][Full Text] [Related]
15. Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era.
McNamara MG; Lwin Z; Jiang H; Chung C; Millar BA; Sahgal A; Laperriere N; Mason WP
J Neurooncol; 2014 Mar; 117(1):153-60. PubMed ID: 24469855
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation.
Capdevila L; Cros S; Ramirez JL; Sanz C; Carrato C; Romeo M; Etxaniz O; Hostalot C; Massuet A; Cuadra JL; Villà S; Balañà C
J Neurooncol; 2014 Mar; 117(1):77-84. PubMed ID: 24395350
[TBL] [Abstract][Full Text] [Related]
17. The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.
Park CK; Lee SH; Kim TM; Choi SH; Park SH; Heo DS; Kim IH; Jung HW
J Neurooncol; 2013 Apr; 112(2):277-83. PubMed ID: 23377829
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.
Wick W; Platten M; Meisner C; Felsberg J; Tabatabai G; Simon M; Nikkhah G; Papsdorf K; Steinbach JP; Sabel M; Combs SE; Vesper J; Braun C; Meixensberger J; Ketter R; Mayer-Steinacker R; Reifenberger G; Weller M;
Lancet Oncol; 2012 Jul; 13(7):707-15. PubMed ID: 22578793
[TBL] [Abstract][Full Text] [Related]
19. IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy.
Minniti G; Scaringi C; Arcella A; Lanzetta G; Di Stefano D; Scarpino S; Bozzao A; Pace A; Villani V; Salvati M; Esposito V; Giangaspero F; Enrici RM
J Neurooncol; 2014 Jun; 118(2):377-383. PubMed ID: 24748470
[TBL] [Abstract][Full Text] [Related]
20. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK
Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]